Damora Therapeutics Inc (DMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DMRA | AZN | AMGN | GILD | VRTX |
| Company | Damora Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 30.99 | 166.22 | 354.66 | 130.10 | 472.15 |
| High | 31.76 | 169.57 | 359.90 | 132.95 | 480.96 |
| Low | 29.89 | 166.21 | 353.95 | 129.40 | 469.60 |
| Latest | 30.95 | 168.37 | 358.32 | 131.70 | 477.08 |
| Change | -0.04 | +3.87 | +3.07 | +1.66 | +0.77 |
| % Change | -0.13% | +2.35% | +0.86% | +1.28% | +0.16% |
| Volume | 622,500 | 2,938,300 | 1,837,900 | 4,467,600 | 1,192,000 |
| 20-Day Average Volume | 985,275 | 2,601,370 | 2,672,795 | 8,332,805 | 2,058,735 |
| Previous Close | 30.99 | 164.50 | 355.25 | 130.04 | 476.31 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.19 | 181.53 | 357.16 | 128.64 | 486.70 |
| 20-Day Raw Stochastic | 93.36% | 12.27% | 58.91% | 60.71% | 36.74% |
| 20-Day Relative Strength | 61.41 | 40.22 | 53.70 | 52.26 | 52.03 |
| Weighted Alpha | -6.12 | +8.97 | +20.28 | +16.40 | +8.77 |
| Today's Opinion | 72% Buy | 88% Sell | 72% Buy | 24% Sell | 88% Buy |
| Previous Opinion | 72% Buy | 88% Sell | 56% Buy | 40% Sell | 72% Buy |
| Last Month's Opinion | 40% Sell | 40% Sell | 40% Buy | 56% Sell | Hold |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.42% since 07/08/26 | -11.05% since 07/08/26 | -2.63% since 07/08/26 | -3.03% since 07/08/26 | -4.28% since 07/08/26 |
| Low | 26.29 on 07/13/26 | 164.45 on 07/14/26 | 353.95 on 07/15/26 | 127.93 on 07/13/26 | 469.60 on 07/15/26 |
| High | 31.76 on 07/15/26 | 180.21 on 07/09/26 | 368.75 on 07/09/26 | 136.06 on 07/09/26 | 500.77 on 07/09/26 |
| 1-Month | |||||
| %Chg | +54.21% since 06/15/26 | -5.02% since 06/15/26 | +2.22% since 06/15/26 | +5.95% since 06/15/26 | +5.91% since 06/15/26 |
| Low | 19.49 on 06/16/26 | 164.45 on 07/14/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 444.21 on 06/16/26 |
| High | 31.76 on 07/15/26 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 137.70 on 07/08/26 | 533.67 on 07/07/26 |
| 3-Month | |||||
| %Chg | +16.31% since 04/15/26 | -16.32% since 04/15/26 | +2.90% since 04/15/26 | -5.77% since 04/15/26 | +8.01% since 04/15/26 |
| Low | 18.59 on 06/10/26 | 164.45 on 07/14/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 31.76 on 07/15/26 | 205.30 on 04/17/26 | 375.25 on 07/07/26 | 140.26 on 04/16/26 | 533.67 on 07/07/26 |
| 6-Month | |||||
| %Chg | +29.23% since 01/15/26 | -10.43% since 01/15/26 | +8.57% since 01/15/26 | +8.61% since 01/15/26 | +8.69% since 01/15/26 |
| Low | 16.50 on 03/20/26 | 164.45 on 07/14/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 33.99 on 02/24/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 533.67 on 07/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,907,528 | 255,124,352 | 191,731,264 | 161,453,744 | 120,889,856 |
| Shares Outstanding, K | 61,553 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -209,840,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -27,780,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 1.46 | 0.24 | 0.41 | 0.32 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.62 on 05/12/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/04/26 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.30 | 16.31 | 15.70 | 28.55 |